Your browser doesn't support javascript.
loading
Changing Antimicrobial Resistance Pattern of Isolates from an ICU Over a 3 Year period.
Khety, Zarine; Mohanta, Guruparasad; Jain, Sachin; Dawoodi, Sameer.
Afiliação
  • Khety Z; Head of Clinical Services and Department of Pharmacy.
  • Mohanta G; Professor, Department of Pharmacy, Annamalai University, PO Annamalai Nagar, Tamil Nadu.
  • Jain S; Head of the Microbiology Department, Saifee Hospital, Mumbai, Maharashtra.
  • Dawoodi S; Medical Intern, MGM Hopsital and Medical College, Navi Mumbai, Maharashtra.
J Assoc Physicians India ; 65(2): 13-16, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28457027
ABSTRACT

OBJECTIVE:

To study the changing patterns of antimicrobial resistance in gram negative bacilli esp. Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa species and Gram positive Staphylococcus aureus isolates from a 37 bedded ICU of a private hospital.

METHODS:

Antibiotic susceptibilities were determined by using disk diffusion and Vitek-2 system.

RESULTS:

A total of 13410 clinical samples were screened over a period of 3 years, among which 16.77 percent (2250 isolates) were culture positive. In recent years there has been an increased incidence of extended-spectrum ß- lactamase (ESBL). The ESBL producing Escherichia coli and Klebsiella pneumonia has shown an increase in resistance to the tune of 80-90% from 2011 to 2013. The prevalence of resistant strains of Acinetobacter species and Pseudomonas aeruginosa has shown an increase in Imipenem and Meropenem resistance at the rate of 75-80%.

CONCLUSIONS:

Antibiotic resistance has shown an increase in gram negative pathogens and thereby has created a significant problem in choosing the right antibiotic for empirical usage. Rise in resistance has left little choice for the clinicians to select antibiotics. Klebsiella pneumonia ESBL and Escherichia coli ESBL have become dominant organisms in the ICU. Piperacillin + Tazobactum, Imipenem and Amikacin have decreased sensitivity against Enterobacter. A number of old antibiotic compounds such as Polymyxins, Fosfomycin, and Aminoglycosides are re-emerging as valuable alternatives for the treatment of ESBL producing bacteria. Cases of MDR Escherichia coli and Klebsiella pneumonia bacteria have increased in recent years and are now the most frequent cause of hospital acquired infections.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Bactérias Gram-Negativas / Unidades de Terapia Intensiva / Antibacterianos Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Assoc Physicians India Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Bactérias Gram-Negativas / Unidades de Terapia Intensiva / Antibacterianos Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Assoc Physicians India Ano de publicação: 2017 Tipo de documento: Article